Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 7, 2007; 13(25): 3517-3522
Published online Jul 7, 2007. doi: 10.3748/wjg.v13.i25.3517
Published online Jul 7, 2007. doi: 10.3748/wjg.v13.i25.3517
Figure 1 RhoA and RhoC siRNAs inhibit RhoA and RhoC protein levels with Western blots.
Lanes 1: SGC7901 cells were untreated; lanes 2-4: or transfected with anti-RhoA or anti-RhoC, Assays were performed 24 h after the end of treatment. Cells were treated with RhoA siRNA (A), RhoC siRNA (B), or control siRNA (C), β-actin served as an internal control.
Figure 2 Anti-RhoA and anti-RhoC siRNAs inhibit RhoA and RhoC gene levels with RT-PCR.
RhoA and RhoC mRNA levels were significantly reduced in the RhoA and RhoC siRNA line. The level of β-actin mRNA after 20 cycles was included as a control.
Figure 3 The values of 490 nm wavelength light absorption in the five group.
- Citation: Sun HW, Tong SL, He J, Wang Q, Zou L, Ma SJ, Tan HY, Luo JF, Wu HX. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway. World J Gastroenterol 2007; 13(25): 3517-3522
- URL: https://www.wjgnet.com/1007-9327/full/v13/i25/3517.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i25.3517